Sale!

Comprehensive Alpha and Beta Thalassemia Gene Panel

Original price was: $626.Current price is: $500.

-20%

The Comprehensive Alpha and Beta Thalassemia Gene Panel is an advanced genetic test that identifies mutations in both alpha and beta globin genes responsible for thalassemia, an inherited blood disorder affecting hemoglobin production. This comprehensive panel utilizes next-generation sequencing (NGS) technology to detect various genetic variants associated with alpha and beta thalassemia, providing crucial information for diagnosis, carrier status determination, and family planning decisions. The test is particularly valuable for individuals with family history of thalassemia, unexplained anemia, or abnormal blood counts. Results help guide appropriate medical management and genetic counseling. The test is priced at $500 USD (discounted from $626 USD) and provides results within 4 weeks using a simple blood sample from an EDTA tube.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Comprehensive Alpha and Beta Thalassemia Gene Panel

Understanding Thalassemia Genetic Testing

The Comprehensive Alpha and Beta Thalassemia Gene Panel represents a cutting-edge diagnostic approach for identifying inherited blood disorders affecting hemoglobin production. Thalassemia is a genetic condition that impacts the body’s ability to produce normal hemoglobin, leading to various degrees of anemia and other health complications. This comprehensive genetic panel provides crucial insights into both alpha and beta globin gene mutations, offering healthcare providers and patients valuable information for diagnosis, treatment planning, and genetic counseling.

What This Advanced Genetic Test Measures

Our comprehensive panel utilizes next-generation sequencing (NGS) technology to analyze the complete genetic landscape of both alpha and beta globin genes. The test specifically detects:

  • Mutations in HBA1 and HBA2 genes responsible for alpha thalassemia
  • Variants in the HBB gene associated with beta thalassemia
  • Common and rare genetic deletions and point mutations
  • Carrier status for various thalassemia types
  • Genetic patterns indicating thalassemia major, minor, or intermedia

Who Should Consider Thalassemia Genetic Testing?

This comprehensive genetic panel is recommended for individuals experiencing:

  • Unexplained chronic anemia or abnormal blood counts
  • Family history of thalassemia or related blood disorders
  • Microcytic hypochromic anemia without iron deficiency
  • Couples planning pregnancy with ethnic backgrounds at higher risk
  • Individuals from Mediterranean, Southeast Asian, African, or Middle Eastern descent
  • Abnormal hemoglobin electrophoresis results
  • Children with failure to thrive or developmental delays

Clinical Benefits of Comprehensive Testing

Choosing our comprehensive thalassemia gene panel offers numerous advantages:

  • Accurate Diagnosis: Provides definitive genetic confirmation of thalassemia type and severity
  • Family Planning Guidance: Identifies carrier status for informed reproductive decisions
  • Personalized Treatment: Enables tailored management strategies based on genetic findings
  • Early Intervention: Facilitates timely treatment initiation for better outcomes
  • Comprehensive Analysis: Simultaneously evaluates both alpha and beta globin genes
  • Genetic Counseling Support: Provides basis for professional genetic counseling sessions

Understanding Your Test Results

Your comprehensive thalassemia gene panel results will provide detailed information about your genetic status:

  • Normal Results: No pathogenic variants detected in alpha or beta globin genes
  • Carrier Status: Identification of one mutated gene copy indicating thalassemia trait
  • Affected Status: Detection of mutations in both gene copies confirming thalassemia
  • Specific Variant Information: Detailed reporting of identified genetic mutations
  • Clinical Correlation: Interpretation of genetic findings in clinical context

All results are reviewed by board-certified genetic specialists and hematologists to ensure accurate interpretation and appropriate clinical recommendations.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $626
Turnaround Time 4 weeks
Sample Type Blood EDTA Tube
Testing Method Next-Generation Sequencing (NGS)

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about thalassemia risk affect your health decisions. Our comprehensive genetic panel provides the clarity you need for informed medical choices and family planning. With advanced NGS technology and expert interpretation, you’ll receive reliable results backed by our team of hematology specialists.

Ready to schedule your Comprehensive Alpha and Beta Thalassemia Gene Panel? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online. Our dedicated staff will guide you through the testing process and ensure you receive the comprehensive care you deserve.